Prediction: Rigetti Computing Stock Will Be Worth This Much in 1 Year

Rigetti’s first-quarter 2026 revenue nearly tripled to $4.4 million, up 198% year over year, and it expanded availability of its Cepheus-1-108Q quantum computer across Amazon Braket and Microsoft Azure Quantum. However, the business still posted a $20.5 million GAAP net loss, carries a lofty 574x price-to-sales ratio, and faces persistent fidelity issues that limit commercial usefulness. The article argues the stock could see further downside despite the operational progress.

Analysis

RGTI’s setup is less about near-term product progress and more about the market’s willingness to underwrite a long-duration science project at software-like multiples. The key second-order issue is that every incremental commercialization win likely expands TAM visibility for the whole quantum cohort, but it also raises the bar for what “proof” looks like; the stock can stay dislocated until error-correction economics become visible in repeatable customer spend, not just headline system availability.

The distribution through AMZN and MSFT is strategically important because it lowers procurement friction and embeds RGTI into the default enterprise cloud buying path. That is a real demand accelerator, but it also shifts bargaining power toward the platforms: over time, the hyperscalers can capture more of the customer relationship and potentially commoditize the access layer, leaving RGTI with high capex and limited pricing power unless fidelity improves meaningfully.

The main risk is a valuation air pocket over the next 1-3 quarters. With revenue still lumpy, any delay in the expected fidelity step-up or slippage in the India order could trigger multiple compression faster than fundamental deterioration, because positioning in high-beta quantum names is likely crowded and momentum-driven. Conversely, a credible move to materially better 2-qubit fidelity would be the catalyst that converts this from a story stock into a recurring-orders narrative, but that looks like a 12-36 month re-rating process rather than a next-quarter event.

Consensus is probably underestimating how much of the current valuation is a financing option on future breakthroughs, not a claim on present earnings power. That means the stock can overshoot on the downside even without operational failure, especially if broader growth multiples de-rate. The cleaner expression is to fade the equity risk premium while keeping exposure to the platform distributors that monetize quantum adoption regardless of which hardware winner emerges.

Key Decisions for Investors

• Short RGTI common on any strength over the next 1-4 weeks; use a tight risk limit because the name can gap on headline fidelity updates, but the payoff is attractive if valuation re-rates toward hardware-like multiples.
• Pair trade: long AMZN or MSFT vs short RGTI for a 3-6 month window; the hyperscalers monetize quantum demand with far lower balance-sheet risk, while RGTI carries execution and dilution overhang.
• For traders willing to keep convexity, buy RGTI put spreads 2-4 months out rather than outright puts; this captures a valuation reset while limiting premium bleed if the stock remains range-bound.
• If already long RGTI, reduce into any post-announcement pop and re-enter only after evidence of sustained order cadence; the key risk/reward inflection is repeatable revenue, not single-system availability.
• Watch for a company update on 2-qubit fidelity improvements; a confirmed step-down in error rates would be the trigger to cover shorts, but absent that, the path of least resistance remains lower.